Peregrine Pharmaceuticals(NASDAQ: PPHM) shares surged 50.37% to $2.03 after the company provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer (NSCLC) in 121 patients. The review was prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA.
Will PPHM Move Higher After Todays Sudden Selling Activities? Dont Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=PPHM
Sequenom, Inc. (NASDAQ: SQNM) shares fell 5.35% to $4.95. The company announced the Company's participation at the upcoming 31(st) Annual JP Morgan Healthcare Conference, to be hosted at the Westin St. Francis Hotel in San Francisco, CA. On Wednesday, January 9th, Chairman and CEO Harry F. Hixson, Jr., Ph.D, and Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will present starting at 11:30 am PT (2:30 pm ET) to provide an overview of and update on the Company.
How Should Investors Trade PPHM After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=PPHM
Illumina, Inc. (NASDAQ: ILMN) stock dropped 8.35% to $50.19 after the company will buy prenatal test company Verinata Health Inc. for $350 million and up to $100 million in milestone payments through 2015. The deal signals another move by a manufacturer of laboratory-based gene-sequencing tools into diagnostics, one step away from consumers. The company will gain control of Redwood City-based Verinatas Verifi non-invasive prenatal test that identifies fetal chromosomal abnormalities, such as those found in Down syndrome.
Get Free Special Trend Analysis On ILMN Here http://beststocksdaily.com/p2/index.php?company=ILMN
Nationstar Mortgage Holdings Inc (NYSE: NSM) shares climbed 17.69% to $39.15 after the company said its wholly-owned unit, Nationstar Mortgage LLC, would acquire around $215 billion in residential mortgage servicing rights or "MSRs", as measured by unpaid principal balance or UPB as of November 30, 2012, and certain other assets from Bank of America.
Get Free Special Trend Analysis On NSM Here http://beststocksdaily.com/p2/index.php?company=NSM
Epocrates, Inc. (NASDAQ: EPOC) shares climbed 21.83% to $11.72 in the early hour after Athenahealth Inc. (ATHN) said it is acquiring Epocrates for about $293 million to gain a leading iPhone app and expand in electronic records. Athenahealth will pay $11.75 a share for San Mateo, California-based Epocrates. The cash offer exceeded Epocrates Jan. 4 closing price by 22%, was approved by both companies boards.
Get Free Special Trend Analysis On EPOC Here http://beststocksdaily.com/p2/index.php?company=EPOC
Beststocksdailys team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdailys instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 WESTWOOD BLVD LOS ANGELES, CA